Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
fda
2
×
life sciences
national blog main
boston
boston blog main
boston top stories
cancer immunotherapy
center for medicare and medicaid services
centers for medicare and medicaid services
cms
cologuard
colon cancer
colorectal cancer
companion diagnostic
daniel o'day
deals
dna
exact sciences
food and drug administration
foundation medicine
foundationone cdx
foundationone heme
genentech
healthcare
medicare
national top stories
new york blog main
osimertinib
roche
rucaparib (rubraca)
san francisco blog main
screening tests
wisconsin
wisconsin blog main
wisconsin top stories
What
stock
2
×
acquire
adversity
agreed
beats
big
billion
broad
cold
confidence
dealing
didn’t
discussed
early
exact
flu
forecasts
foundation
gain
genentech
historically
industry
leaders
medicine
momentum
morning
obs
panels
pay
pays
picked
price
profiling
quarterly
recently
redux
remaining
rest
roche
sciences
Language
Current search:
stock
×
fda
×
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
6 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up
